WhaleCreep
Home › Funds › 22NW, LP › Q4 2025

22NW, LP 13F holdings, Q4 2025

Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →

22NW, LP disclosed 20 US equity positions worth $237.6m in its Q4 2025 13F filing. The largest position was ANEB at 35.7% of the reported book, followed by FSTR and LFCR. Against the Q3 2025 filing, it opened 1 new position, added to 2 and reduced 2 among the top 20 holdings.

← Q3 2025 · Q1 2026 →

What did 22NW, LP own in Q4 2025? Top 20 positions

#StockSectorWeightValueSharesΔ sharesvs Q3 2025
1 ANEB ANEBULO PHARMACEUTICALS INC 35.7%$84.8m15,467,300 0% held
2 FSTR FOSTER L B CO Industrials 13.5%$32.1m1,191,046 -9% reduced
3 LFCR LIFECORE BIOMEDICAL INC 9.7%$23.0m1,254 0% held
4 NKTR NEKTAR THERAPEUTICS Healthcare 5.9%$14.0m331,115 0% held
5 RGNX REGENXBIO INC Healthcare 5.6%$13.3m923,679 0% held
6 MLYS MINERALYS THERAPEUTICS INC Healthcare 5.5%$13.0m358,325 0% held
7 SRI STONERIDGE INC Consumer Cyclical 5.3%$12.7m2,192,764 4% added
8 MEC MAYVILLE ENGR CO INC 3.3%$7.8m414,280 4% added
9 CULP CULP INC 2.8%$6.6m1,859,061 0% held
10 PHENIXFIN CORP 2.2%$5.2m117,885 0% held
11 MGTX MEIRAGTX HLDGS PLC 2.0%$4.7m586,519 0% held
12 CMT CORE MOLDING TECHNOLOGIES 1.9%$4.5m222,738 0% held
13 NSP INSPERITY INC Industrials 1.6%$3.7m96,300 – new
14 UFI UNIFI INC Consumer Cyclical 1.3%$3.0m852,455 -13% reduced
15 FB1 FARMER BROS CO 1.2%$2.9m1,955,526 0% held
16 TISI TEAM INC 1.0%$2.4m170,187 0% held
17 RZLT REZOLUTE INC 0.8%$1.9m820,653 0% held
18 ELDN ELEDON PHARMACEUTICALS INC 0.4%$960.9k636,364 0% held
19 SSKN STRATA SKIN SCIENCES INC 0.3%$676.6k536,995 0% held
20 PSYCHEMEDICS CORPORATION CMN 0.2%$441.7k276,034 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.